TOP > 外国特許検索 > RETROVIRAL PROLIFERATION INHIBITOR, RETROVIRAL INFECTION PROPHYLACTIC DRUG CONTAINING SAME, AND RETROVIRAL INFECTION ONSET PROPHYLACTIC DRUG

RETROVIRAL PROLIFERATION INHIBITOR, RETROVIRAL INFECTION PROPHYLACTIC DRUG CONTAINING SAME, AND RETROVIRAL INFECTION ONSET PROPHYLACTIC DRUG

外国特許コード F190009734
整理番号 (S2017-0695-N0)
掲載日 2019年4月25日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2018JP021962
国際公開番号 WO 2018225847
国際出願日 平成30年6月8日(2018.6.8)
国際公開日 平成30年12月13日(2018.12.13)
優先権データ
  • 特願2017-113196 (2017.6.8) JP
発明の名称 (英語) RETROVIRAL PROLIFERATION INHIBITOR, RETROVIRAL INFECTION PROPHYLACTIC DRUG CONTAINING SAME, AND RETROVIRAL INFECTION ONSET PROPHYLACTIC DRUG
発明の概要(英語) Provided is an agent that: inhibits the proliferation of retroviruses involved in retroviral infections such as acquired immunodeficiency syndrome, HTLV-1-associated myelopathy, and adult T cell leukemia; prevents retroviral infection; and prevents the onset of retroviral infection. A retroviral proliferation inhibitor characterized by containing metal-bonded fucoidan in which one or more metals selected from the group consisting of potassium, calcium, magnesium, zinc, and selenium are bonded to the sulfate groups of fucoidan, the zinc content in the metal-bonded fucoidan being 0.005% or higher per fucoidan 1 in terms of mass when the metal is zinc; a retroviral infection prophylactic drug containing the retroviral proliferation inhibitor; and a retroviral infection onset prophylactic drug.
従来技術、競合技術の概要(英語) BACKGROUND ART
Retrovirus, stranded RNA of the gene 1 as a virus having a spherical shape. This retrovirus, oncoviruses, lentiviruses, spumaviruses several divided into subfamilies.
Retrovirus family of these, such as HIV-1, 2 pmBCmCNluci family Acquired Immune Deficiency Syndrome (AIDS) and is associated, oncoviruses HTLV-1, 2 family (HAM) is associated with spinal disease HTLV-1, T-cell leukemia (ATL) adult, uveitis HTLV-1 (HU) associated with known to be associated with.
This treatment of a disease associated with a retrovirus to an anti-viral agent using a plurality of anti-retroviral therapy is the mainstream (for example, the integrase inhibitor 1 agent and the reverse transcriptase inhibitor 2 of the combination therapy), and then the high cost and the maintenance of the medication compliance, and effectiveness is also a problem, not widely available (Non-Patent Document 1).
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • SOUTH PRODUCT LTD.
  • University of the Ryukyus
  • 発明者(英語)
  • IHA Masahiko
  • TOMORI Makoto
  • TANAKA Yuetsu
  • FUKUSHIMA Takuya
  • MIYARA Megumi
  • IMAIZUMI Naoki
国際特許分類(IPC)
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記「問合せ先」まで直接お問い合わせ下さい。

PAGE TOP

close
close
close
close
close
close